Combined use of anti PD-1 and anti M-CSF antibodies in the treatment of cancer

The present application n relates to a pharmaceutical composition comprising a PD-1 antibody and an M-CSF antibody. The combination can be administered independently or separately, in a quantity which is therapeutically effective for the treatment of cancer.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fjaellskog, Marie-Louise, Cipolletta, Daniela, Cameron, John Scott, Cao, Zhu, MacIsaac, Kenzie
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present application n relates to a pharmaceutical composition comprising a PD-1 antibody and an M-CSF antibody. The combination can be administered independently or separately, in a quantity which is therapeutically effective for the treatment of cancer.